fluoxetine has been researched along with Enterovirus Infections in 4 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Enterovirus Infections: Diseases caused by ENTEROVIRUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Enterovirus infections pose a serious threat for patients with humoral deficiencies and may be lethal, whilst the efficacy of proposed treatment options such as corticosteroids, intravenous immunoglobulins and fluoxetine remains debated." | 4.12 | Antiviral treatment with fluoxetine for rituximab-associated chronic echovirus 13 meningoencephalitis and myofasciitis. ( Boeckx, N; Demaerel, P; Dubois, B; Jentjens, S; Kuppeveld, FJM; Laenen, L; Lens, G; Thal, DR; van der Elst, KCM; Van Nieuwenhuyse, T; Verhaert, N; Vermeersch, G; Woei-A-Jin, FJSH; Wollants, E, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vermeersch, G | 1 |
| Laenen, L | 1 |
| Lens, G | 1 |
| van der Elst, KCM | 1 |
| Thal, DR | 1 |
| Jentjens, S | 1 |
| Demaerel, P | 1 |
| Van Nieuwenhuyse, T | 1 |
| Wollants, E | 1 |
| Boeckx, N | 1 |
| Verhaert, N | 1 |
| Dubois, B | 1 |
| Kuppeveld, FJM | 1 |
| Woei-A-Jin, FJSH | 1 |
| Chetty, K | 1 |
| Cheng, I | 1 |
| Kaliakatsos, M | 1 |
| Gonzalez-Granado, LI | 1 |
| Klapsa, D | 1 |
| Martin, J | 1 |
| Bamford, A | 1 |
| Breuer, J | 1 |
| Booth, C | 1 |
| Bauer, L | 1 |
| Manganaro, R | 1 |
| Zonsics, B | 1 |
| Hurdiss, DL | 1 |
| Zwaagstra, M | 1 |
| Donselaar, T | 1 |
| Welter, NGE | 1 |
| van Kleef, RGDM | 1 |
| Lopez, ML | 1 |
| Bevilacqua, F | 1 |
| Raman, T | 1 |
| Ferla, S | 1 |
| Bassetto, M | 1 |
| Neyts, J | 1 |
| Strating, JRPM | 1 |
| Westerink, RHS | 1 |
| Brancale, A | 1 |
| van Kuppeveld, FJM | 1 |
| Gofshteyn, J | 1 |
| Cárdenas, AM | 1 |
| Bearden, D | 1 |
4 other studies available for fluoxetine and Enterovirus Infections
| Article | Year |
|---|---|
Antiviral treatment with fluoxetine for rituximab-associated chronic echovirus 13 meningoencephalitis and myofasciitis.
Topics: Antiviral Agents; Echovirus Infections; Enterovirus B, Human; Enterovirus Infections; Fluoxetine; Hu | 2022 |
Case report: Novel treatment regimen for
Topics: Amides; Antiviral Agents; Encephalitis, Viral; Enterovirus; Enterovirus Infections; Fluoxetine; Huma | 2022 |
Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C.
Topics: Antigens, Viral; Antiviral Agents; Carrier Proteins; Drug Discovery; Enterovirus; Enterovirus Infect | 2020 |
Treatment of Chronic Enterovirus Encephalitis With Fluoxetine in a Patient With X-Linked Agammaglobulinemia.
Topics: Agammaglobulinemia; Antiviral Agents; Child, Preschool; Chronic Disease; Encephalitis, Viral; Entero | 2016 |